

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemoglobin metabolic process (GO:0020027) | 7.93307471 |
| 2 | erythrocyte maturation (GO:0043249) | 7.49728394 |
| 3 | protoporphyrinogen IX metabolic process (GO:0046501) | 6.37282119 |
| 4 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.04589047 |
| 5 | sarcomere organization (GO:0045214) | 5.83254595 |
| 6 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.81976441 |
| 7 | plasma membrane repair (GO:0001778) | 5.76662999 |
| 8 | * erythrocyte development (GO:0048821) | 5.70144439 |
| 9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.61297275 |
| 10 | actin-myosin filament sliding (GO:0033275) | 5.53487013 |
| 11 | muscle filament sliding (GO:0030049) | 5.53487013 |
| 12 | regulation of response to osmotic stress (GO:0047484) | 5.51987022 |
| 13 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.50878373 |
| 14 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.50330018 |
| 15 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.47399703 |
| 16 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.26661776 |
| 17 | cardiac myofibril assembly (GO:0055003) | 5.24205413 |
| 18 | myofibril assembly (GO:0030239) | 5.20242837 |
| 19 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.18504709 |
| 20 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.12050691 |
| 21 | cardiac muscle contraction (GO:0060048) | 5.10163687 |
| 22 | regulation of cell communication by electrical coupling (GO:0010649) | 5.07844045 |
| 23 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.02367795 |
| 24 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.91555145 |
| 25 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.85771272 |
| 26 | regulation of skeletal muscle contraction (GO:0014819) | 4.80440344 |
| 27 | * porphyrin-containing compound biosynthetic process (GO:0006779) | 4.77932808 |
| 28 | iron ion import (GO:0097286) | 4.61420726 |
| 29 | regulation of actin filament-based movement (GO:1903115) | 4.59143605 |
| 30 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.56255385 |
| 31 | striated muscle contraction (GO:0006941) | 4.51712646 |
| 32 | cell communication by electrical coupling (GO:0010644) | 4.46933327 |
| 33 | * myeloid cell development (GO:0061515) | 4.45765977 |
| 34 | actin-mediated cell contraction (GO:0070252) | 4.44174779 |
| 35 | sodium ion export (GO:0071436) | 4.39042028 |
| 36 | regulation of relaxation of muscle (GO:1901077) | 4.33913517 |
| 37 | * tetrapyrrole biosynthetic process (GO:0033014) | 4.32186901 |
| 38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.29202037 |
| 39 | cell communication involved in cardiac conduction (GO:0086065) | 4.25336417 |
| 40 | regulation of membrane repolarization (GO:0060306) | 4.20140835 |
| 41 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.15770046 |
| 42 | * tetrapyrrole metabolic process (GO:0033013) | 4.15593618 |
| 43 | heme biosynthetic process (GO:0006783) | 4.10217259 |
| 44 | potassium ion import (GO:0010107) | 4.07407283 |
| 45 | neuronal action potential propagation (GO:0019227) | 4.05163523 |
| 46 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.03957031 |
| 47 | granulocyte differentiation (GO:0030851) | 4.00159710 |
| 48 | megakaryocyte development (GO:0035855) | 3.93710087 |
| 49 | tricarboxylic acid cycle (GO:0006099) | 3.93362712 |
| 50 | actomyosin structure organization (GO:0031032) | 3.92571404 |
| 51 | erythrocyte differentiation (GO:0030218) | 3.92372716 |
| 52 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.91510897 |
| 53 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.91510897 |
| 54 | definitive hemopoiesis (GO:0060216) | 3.88806231 |
| 55 | regulation of striated muscle contraction (GO:0006942) | 3.79775161 |
| 56 | platelet formation (GO:0030220) | 3.79769968 |
| 57 | skeletal muscle contraction (GO:0003009) | 3.79124790 |
| 58 | cardiac muscle cell development (GO:0055013) | 3.67161842 |
| 59 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.66848484 |
| 60 | response to lead ion (GO:0010288) | 3.66768133 |
| 61 | response to methylmercury (GO:0051597) | 3.66324258 |
| 62 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.65918309 |
| 63 | cellular potassium ion homeostasis (GO:0030007) | 3.64393848 |
| 64 | membrane depolarization during action potential (GO:0086010) | 3.62017420 |
| 65 | regulation of erythrocyte differentiation (GO:0045646) | 3.60245465 |
| 66 | regulation of the force of heart contraction (GO:0002026) | 3.57793421 |
| 67 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.56848576 |
| 68 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.56633059 |
| 69 | adult heart development (GO:0007512) | 3.52994633 |
| 70 | response to inactivity (GO:0014854) | 3.50657541 |
| 71 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.48707781 |
| 72 | cardiac muscle hypertrophy (GO:0003300) | 3.47055286 |
| 73 | one-carbon compound transport (GO:0019755) | 3.46701073 |
| 74 | positive regulation of cation channel activity (GO:2001259) | 3.45021774 |
| 75 | cerebellar granule cell differentiation (GO:0021707) | 3.43088926 |
| 76 | carnitine shuttle (GO:0006853) | 3.42036122 |
| 77 | actin filament-based movement (GO:0030048) | 3.41666418 |
| 78 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.41092514 |
| 79 | * porphyrin-containing compound metabolic process (GO:0006778) | 3.40830220 |
| 80 | response to insecticide (GO:0017085) | 3.38543958 |
| 81 | cardiac cell development (GO:0055006) | 3.38219701 |
| 82 | striated muscle hypertrophy (GO:0014897) | 3.37215420 |
| 83 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.36581197 |
| 84 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.30598600 |
| 85 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.29452421 |
| 86 | relaxation of cardiac muscle (GO:0055119) | 3.29434993 |
| 87 | negative regulation of protein localization to cell surface (GO:2000009) | 3.27356721 |
| 88 | skeletal muscle fiber development (GO:0048741) | 3.26379457 |
| 89 | embryonic hemopoiesis (GO:0035162) | 3.25432831 |
| 90 | creatine metabolic process (GO:0006600) | 3.25242638 |
| 91 | regulation of RNA export from nucleus (GO:0046831) | 3.23316255 |
| 92 | synaptic vesicle maturation (GO:0016188) | 3.21389052 |
| 93 | skeletal muscle adaptation (GO:0043501) | 3.21184071 |
| 94 | regulation of sarcomere organization (GO:0060297) | 3.17928258 |
| 95 | locomotory exploration behavior (GO:0035641) | 3.17622565 |
| 96 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.15256855 |
| 97 | regulation of cardiac muscle contraction (GO:0055117) | 3.15095453 |
| 98 | regulation of cation channel activity (GO:2001257) | 3.13684096 |
| 99 | cellular response to dexamethasone stimulus (GO:0071549) | 3.12847466 |
| 100 | glycine transport (GO:0015816) | 3.12125445 |
| 101 | activation of protein kinase A activity (GO:0034199) | 3.11481152 |
| 102 | response to muscle activity (GO:0014850) | 3.07368555 |
| 103 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.07206783 |
| 104 | response to arsenic-containing substance (GO:0046685) | 3.06349689 |
| 105 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.05908682 |
| 106 | muscle contraction (GO:0006936) | 3.04500420 |
| 107 | positive regulation of myotube differentiation (GO:0010831) | 3.03398915 |
| 108 | negative regulation of potassium ion transport (GO:0043267) | 3.03069183 |
| 109 | regulation of cofactor metabolic process (GO:0051193) | 3.02665787 |
| 110 | regulation of coenzyme metabolic process (GO:0051196) | 3.02665787 |
| 111 | cardiac muscle cell action potential (GO:0086001) | 3.01988803 |
| 112 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.01408463 |
| 113 | positive regulation of granulocyte differentiation (GO:0030854) | 3.00558807 |
| 114 | gas transport (GO:0015669) | 2.99097247 |
| 115 | bicarbonate transport (GO:0015701) | 2.98322327 |
| 116 | actin filament capping (GO:0051693) | 2.97253186 |
| 117 | cardiac conduction (GO:0061337) | 2.96999766 |
| 118 | regulation of synapse structural plasticity (GO:0051823) | 2.96458271 |
| 119 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.94745032 |
| 120 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 2.94329695 |
| 121 | regulation of platelet aggregation (GO:0090330) | 2.93784064 |
| 122 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.92465886 |
| 123 | myotube cell development (GO:0014904) | 2.91917397 |
| 124 | muscle system process (GO:0003012) | 2.91823486 |
| 125 | carnitine transmembrane transport (GO:1902603) | 2.90825786 |
| 126 | muscle hypertrophy (GO:0014896) | 2.88801503 |
| 127 | positive regulation of potassium ion transport (GO:0043268) | 2.88627672 |
| 128 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.87650553 |
| 129 | regulation of heart rate (GO:0002027) | 2.86806634 |
| 130 | NADH metabolic process (GO:0006734) | 2.86303729 |
| 131 | neuromuscular process controlling posture (GO:0050884) | 2.85385917 |
| 132 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.84991679 |
| 133 | response to dexamethasone (GO:0071548) | 2.84168771 |
| 134 | heme metabolic process (GO:0042168) | 2.83807322 |
| 135 | skeletal muscle tissue regeneration (GO:0043403) | 2.81247077 |
| 136 | N-terminal protein amino acid acetylation (GO:0006474) | 2.78642723 |
| 137 | negative regulation of necroptotic process (GO:0060546) | 2.76475988 |
| 138 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.76318993 |
| 139 | striated muscle adaptation (GO:0014888) | 2.76289793 |
| 140 | cellular response to arsenic-containing substance (GO:0071243) | 2.75214754 |
| 141 | positive regulation of gluconeogenesis (GO:0045722) | 2.74780703 |
| 142 | pigment biosynthetic process (GO:0046148) | 2.74419201 |
| 143 | negative regulation of actin filament depolymerization (GO:0030835) | 2.73687811 |
| 144 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.70089679 |
| 145 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.66922642 |
| 146 | 2-oxoglutarate metabolic process (GO:0006103) | 2.66593709 |
| 147 | glycogen biosynthetic process (GO:0005978) | 2.65307001 |
| 148 | glucan biosynthetic process (GO:0009250) | 2.65307001 |
| 149 | glycogen catabolic process (GO:0005980) | 2.64075153 |
| 150 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.62774648 |
| 151 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.57132627 |
| 152 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.55187465 |
| 153 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.55187465 |
| 154 | glucan catabolic process (GO:0009251) | 2.54346097 |
| 155 | oxygen transport (GO:0015671) | 10.5690988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.35881410 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.29429871 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.85660689 |
| 4 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.49438120 |
| 5 | * GATA1_19941826_ChIP-Seq_K562_Human | 3.30566764 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.22232136 |
| 7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.92572305 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.89794906 |
| 9 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.69424973 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.54195820 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.53362726 |
| 12 | NCOR1_26117541_ChIP-Seq_K562_Human | 2.45551766 |
| 13 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.44630912 |
| 14 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 2.39182761 |
| 15 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.29605385 |
| 16 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.26866956 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.26848809 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.25480690 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.17084541 |
| 20 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.16180415 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.08742770 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.05982568 |
| 23 | KDM2B_26808549_Chip-Seq_K562_Human | 2.03798343 |
| 24 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.01334566 |
| 25 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.01334566 |
| 26 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.95856992 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.93814366 |
| 28 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.90561734 |
| 29 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.88391191 |
| 30 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.87313022 |
| 31 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.85929338 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.83335730 |
| 33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.83335730 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.81601588 |
| 35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.80656671 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.78963277 |
| 37 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78544986 |
| 38 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.77203391 |
| 39 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.67793360 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.67306532 |
| 41 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.67086729 |
| 42 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.65337010 |
| 43 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62853659 |
| 44 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.62722281 |
| 45 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.60563222 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.58367374 |
| 47 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.56813765 |
| 48 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.56253899 |
| 49 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.54963884 |
| 50 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51246679 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.49731279 |
| 52 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.49158931 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47548173 |
| 54 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.46373593 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42247353 |
| 56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40884817 |
| 57 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.40431659 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37771234 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37637408 |
| 60 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.37396800 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37098490 |
| 62 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36852010 |
| 63 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.34243913 |
| 64 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.31812692 |
| 65 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.31675369 |
| 66 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31006387 |
| 67 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.29987955 |
| 68 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26828362 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26798408 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26622345 |
| 71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25480680 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24544572 |
| 73 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23556866 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.23039424 |
| 75 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22963067 |
| 76 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21971645 |
| 77 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21948493 |
| 78 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.21326571 |
| 79 | P68_20966046_ChIP-Seq_HELA_Human | 1.21248325 |
| 80 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19609438 |
| 81 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19018748 |
| 82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18657377 |
| 83 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.18224934 |
| 84 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.18194208 |
| 85 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17438613 |
| 86 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.16343854 |
| 87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15176618 |
| 88 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14851593 |
| 89 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14763720 |
| 90 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13352755 |
| 91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12722761 |
| 92 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.12652258 |
| 93 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.12571135 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09930030 |
| 95 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.09565362 |
| 96 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.09464454 |
| 97 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.07281999 |
| 98 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.07071646 |
| 99 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.06667661 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06502230 |
| 101 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.06438130 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06075811 |
| 103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05932527 |
| 104 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.04434481 |
| 105 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.04381734 |
| 106 | * AR_19668381_ChIP-Seq_PC3_Human | 1.03951755 |
| 107 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02546057 |
| 108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02523158 |
| 109 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.01996773 |
| 110 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.01391327 |
| 111 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01052670 |
| 112 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00174648 |
| 113 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99318059 |
| 114 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99067915 |
| 115 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.98982329 |
| 116 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98611782 |
| 117 | MAF_26560356_Chip-Seq_TH2_Human | 0.98531817 |
| 118 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.97691246 |
| 119 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.97436247 |
| 120 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96340488 |
| 121 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96282545 |
| 122 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94838555 |
| 123 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94430637 |
| 124 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92471676 |
| 125 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92408648 |
| 126 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.92134378 |
| 127 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91250971 |
| 128 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90408740 |
| 129 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.89597388 |
| 130 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.88886733 |
| 131 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.87926372 |
| 132 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.87919078 |
| 133 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.87434740 |
| 134 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87344523 |
| 135 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86288470 |
| 136 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85805919 |
| 137 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85287377 |
| 138 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84407927 |
| 139 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.84184029 |
| 140 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.83797478 |
| 141 | SA1_27219007_Chip-Seq_Bcells_Human | 0.82721430 |
| 142 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.82268078 |
| 143 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81658287 |
| 144 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81148378 |
| 145 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.80141024 |
| 146 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.77345756 |
| 147 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77036238 |
| 148 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.75418993 |
| 149 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.73919218 |
| 150 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.73250565 |
| 151 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.72197250 |
| 152 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.70327700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 5.21795099 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.15886795 |
| 3 | MP0000751_myopathy | 4.69813376 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 4.23049838 |
| 5 | MP0000749_muscle_degeneration | 4.07207251 |
| 6 | MP0004215_abnormal_myocardial_fiber | 3.88264814 |
| 7 | MP0004084_abnormal_cardiac_muscle | 3.81068583 |
| 8 | MP0005451_abnormal_body_composition | 3.68924079 |
| 9 | MP0004036_abnormal_muscle_relaxation | 3.47414429 |
| 10 | * MP0003656_abnormal_erythrocyte_physiolo | 3.22737597 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.91403131 |
| 12 | MP0004087_abnormal_muscle_fiber | 2.70573934 |
| 13 | MP0005330_cardiomyopathy | 2.64333532 |
| 14 | MP0000747_muscle_weakness | 2.63203680 |
| 15 | MP0001545_abnormal_hematopoietic_system | 2.61924403 |
| 16 | MP0005397_hematopoietic_system_phenotyp | 2.61924403 |
| 17 | MP0002106_abnormal_muscle_physiology | 2.51870346 |
| 18 | MP0008775_abnormal_heart_ventricle | 2.44612549 |
| 19 | MP0005620_abnormal_muscle_contractility | 2.40463073 |
| 20 | MP0002972_abnormal_cardiac_muscle | 2.33460837 |
| 21 | MP0002269_muscular_atrophy | 2.33446437 |
| 22 | MP0003137_abnormal_impulse_conducting | 2.32793834 |
| 23 | MP0004130_abnormal_muscle_cell | 2.32292971 |
| 24 | MP0009046_muscle_twitch | 2.27807641 |
| 25 | MP0000759_abnormal_skeletal_muscle | 2.24178982 |
| 26 | MP0004484_altered_response_of | 2.22082753 |
| 27 | MP0005369_muscle_phenotype | 2.08005153 |
| 28 | MP0000750_abnormal_muscle_regeneration | 2.07012221 |
| 29 | MP0008569_lethality_at_weaning | 1.97257693 |
| 30 | * MP0004147_increased_porphyrin_level | 1.82299661 |
| 31 | MP0004085_abnormal_heartbeat | 1.81198886 |
| 32 | MP0004233_abnormal_muscle_weight | 1.80862871 |
| 33 | MP0003635_abnormal_synaptic_transmissio | 1.78317619 |
| 34 | MP0005385_cardiovascular_system_phenoty | 1.73813451 |
| 35 | MP0001544_abnormal_cardiovascular_syste | 1.73813451 |
| 36 | MP0010630_abnormal_cardiac_muscle | 1.71102269 |
| 37 | MP0004270_analgesia | 1.69571471 |
| 38 | MP0008260_abnormal_autophagy | 1.65322995 |
| 39 | MP0008995_early_reproductive_senescence | 1.64463573 |
| 40 | MP0002822_catalepsy | 1.63038379 |
| 41 | MP0009278_abnormal_bone_marrow | 1.59586331 |
| 42 | MP0004510_myositis | 1.57321569 |
| 43 | MP0006138_congestive_heart_failure | 1.54345315 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 1.53700757 |
| 45 | MP0002332_abnormal_exercise_endurance | 1.51686391 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.51614050 |
| 47 | MP0001968_abnormal_touch/_nociception | 1.49316642 |
| 48 | MP0002272_abnormal_nervous_system | 1.42958884 |
| 49 | MP0002734_abnormal_mechanical_nocicepti | 1.40213990 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.35840662 |
| 51 | MP0002064_seizures | 1.35662013 |
| 52 | MP0003303_peritoneal_inflammation | 1.33845387 |
| 53 | MP0009745_abnormal_behavioral_response | 1.33390981 |
| 54 | MP0002736_abnormal_nociception_after | 1.32502490 |
| 55 | MP0002067_abnormal_sensory_capabilities | 1.29523791 |
| 56 | MP0001440_abnormal_grooming_behavior | 1.21796123 |
| 57 | MP0003221_abnormal_cardiomyocyte_apopto | 1.18700029 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.17099367 |
| 59 | MP0001529_abnormal_vocalization | 1.15051802 |
| 60 | * MP0005636_abnormal_mineral_homeostasis | 1.12768755 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.10588769 |
| 62 | MP0002063_abnormal_learning/memory/cond | 1.08996406 |
| 63 | MP0005423_abnormal_somatic_nervous | 1.06851524 |
| 64 | MP0001661_extended_life_span | 1.04153541 |
| 65 | MP0004924_abnormal_behavior | 1.02204236 |
| 66 | MP0005386_behavior/neurological_phenoty | 1.02204236 |
| 67 | MP0003828_pulmonary_edema | 1.02155073 |
| 68 | MP0003111_abnormal_nucleus_morphology | 1.00732747 |
| 69 | MP0006035_abnormal_mitochondrial_morpho | 0.99003324 |
| 70 | MP0003880_abnormal_central_pattern | 0.98680501 |
| 71 | MP0003329_amyloid_beta_deposits | 0.96844269 |
| 72 | MP0004142_abnormal_muscle_tone | 0.95480236 |
| 73 | MP0002108_abnormal_muscle_morphology | 0.95350809 |
| 74 | MP0002733_abnormal_thermal_nociception | 0.95310642 |
| 75 | MP0001970_abnormal_pain_threshold | 0.94497490 |
| 76 | MP0005666_abnormal_adipose_tissue | 0.93030726 |
| 77 | MP0004043_abnormal_pH_regulation | 0.88652018 |
| 78 | MP0002396_abnormal_hematopoietic_system | 0.83141404 |
| 79 | MP0002572_abnormal_emotion/affect_behav | 0.83027136 |
| 80 | MP0003633_abnormal_nervous_system | 0.81188432 |
| 81 | MP0004858_abnormal_nervous_system | 0.80652018 |
| 82 | * MP0000266_abnormal_heart_morphology | 0.80583574 |
| 83 | * MP0002066_abnormal_motor_capabilities/c | 0.79630393 |
| 84 | MP0008961_abnormal_basal_metabolism | 0.79528099 |
| 85 | MP0004811_abnormal_neuron_physiology | 0.79328034 |
| 86 | MP0000013_abnormal_adipose_tissue | 0.78549440 |
| 87 | MP0005375_adipose_tissue_phenotype | 0.78494411 |
| 88 | MP0002127_abnormal_cardiovascular_syste | 0.78267434 |
| 89 | MP0002184_abnormal_innervation | 0.77819657 |
| 90 | * MP0002398_abnormal_bone_marrow | 0.76898851 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 0.76368966 |
| 92 | MP0003186_abnormal_redox_activity | 0.75368303 |
| 93 | MP0000003_abnormal_adipose_tissue | 0.74992096 |
| 94 | MP0000733_abnormal_muscle_development | 0.74548452 |
| 95 | MP0003191_abnormal_cellular_cholesterol | 0.74203009 |
| 96 | MP0001486_abnormal_startle_reflex | 0.72522903 |
| 97 | MP0000689_abnormal_spleen_morphology | 0.72114671 |
| 98 | MP0005266_abnormal_metabolism | 0.69816073 |
| 99 | MP0003631_nervous_system_phenotype | 0.68727015 |
| 100 | MP0009931_abnormal_skin_appearance | 0.68594513 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.68298110 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.68079975 |
| 103 | MP0002971_abnormal_brown_adipose | 0.67281916 |
| 104 | * MP0002722_abnormal_immune_system | 0.66612412 |
| 105 | MP0008872_abnormal_physiological_respon | 0.66431209 |
| 106 | MP0000955_abnormal_spinal_cord | 0.66429703 |
| 107 | MP0006276_abnormal_autonomic_nervous | 0.66019539 |
| 108 | MP0003950_abnormal_plasma_membrane | 0.65800621 |
| 109 | MP0002234_abnormal_pharynx_morphology | 0.65112872 |
| 110 | MP0001501_abnormal_sleep_pattern | 0.64792199 |
| 111 | MP0003879_abnormal_hair_cell | 0.64642894 |
| 112 | MP0009780_abnormal_chondrocyte_physiolo | 0.64128792 |
| 113 | MP0005623_abnormal_meninges_morphology | 0.63106746 |
| 114 | MP0002132_abnormal_respiratory_system | 0.61447086 |
| 115 | MP0005535_abnormal_body_temperature | 0.61172362 |
| 116 | MP0003172_abnormal_lysosome_physiology | 0.60927937 |
| 117 | MP0008770_decreased_survivor_rate | 0.60792266 |
| 118 | MP0002009_preneoplasia | 0.59820208 |
| 119 | MP0003045_fibrosis | 0.59214868 |
| 120 | MP0005187_abnormal_penis_morphology | 0.56873121 |
| 121 | MP0009697_abnormal_copulation | 0.56198328 |
| 122 | MP0000372_irregular_coat_pigmentation | 0.56097800 |
| 123 | MP0003705_abnormal_hypodermis_morpholog | 0.55659877 |
| 124 | MP0002877_abnormal_melanocyte_morpholog | 0.55479219 |
| 125 | MP0008874_decreased_physiological_sensi | 0.54829381 |
| 126 | MP0000920_abnormal_myelination | 0.53346511 |
| 127 | MP0005165_increased_susceptibility_to | 0.53258085 |
| 128 | MP0000343_altered_response_to | 0.53085715 |
| 129 | MP0000313_abnormal_cell_death | 0.50688182 |
| 130 | MP0002078_abnormal_glucose_homeostasis | 0.50305857 |
| 131 | MP0008057_abnormal_DNA_replication | 0.49972578 |
| 132 | MP0000609_abnormal_liver_physiology | 0.43939342 |
| 133 | * MP0002429_abnormal_blood_cell | 0.43568052 |
| 134 | MP0000015_abnormal_ear_pigmentation | 0.43084437 |
| 135 | MP0001784_abnormal_fluid_regulation | 0.42515810 |
| 136 | MP0005452_abnormal_adipose_tissue | 0.41150501 |
| 137 | * MP0000703_abnormal_thymus_morphology | 0.40442956 |
| 138 | MP0005645_abnormal_hypothalamus_physiol | 0.39247607 |
| 139 | MP0005167_abnormal_blood-brain_barrier | 0.39226931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 6.32099021 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 6.00053557 |
| 3 | Sudden death (HP:0001699) | 5.92805190 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 5.65842618 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.62911090 |
| 6 | Muscle fiber splitting (HP:0003555) | 4.70495083 |
| 7 | Hyporeflexia of lower limbs (HP:0002600) | 4.53589712 |
| 8 | Abnormality of the calf musculature (HP:0001430) | 4.46589737 |
| 9 | Difficulty running (HP:0009046) | 4.34643275 |
| 10 | * Poikilocytosis (HP:0004447) | 4.32772387 |
| 11 | Myoglobinuria (HP:0002913) | 4.31794105 |
| 12 | Myotonia (HP:0002486) | 4.29386293 |
| 13 | Abnormal hemoglobin (HP:0011902) | 4.27041226 |
| 14 | Bundle branch block (HP:0011710) | 4.26208084 |
| 15 | Ventricular tachycardia (HP:0004756) | 4.25478483 |
| 16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.11373123 |
| 17 | Subaortic stenosis (HP:0001682) | 4.11373123 |
| 18 | Atrial fibrillation (HP:0005110) | 4.11360031 |
| 19 | Microcytic anemia (HP:0001935) | 3.96812540 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 3.94847247 |
| 21 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.88962644 |
| 22 | Primary atrial arrhythmia (HP:0001692) | 3.84597620 |
| 23 | Muscle fiber inclusion bodies (HP:0100299) | 3.78042454 |
| 24 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.73416625 |
| 25 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.69416553 |
| 26 | Supraventricular tachycardia (HP:0004755) | 3.69075058 |
| 27 | Ventricular fibrillation (HP:0001663) | 3.65674469 |
| 28 | Supraventricular arrhythmia (HP:0005115) | 3.59516471 |
| 29 | Dysmetric saccades (HP:0000641) | 3.52097022 |
| 30 | Increased connective tissue (HP:0009025) | 3.47199414 |
| 31 | Prolonged QT interval (HP:0001657) | 3.36519143 |
| 32 | Muscle stiffness (HP:0003552) | 3.35360931 |
| 33 | Lipoatrophy (HP:0100578) | 3.29095257 |
| 34 | Diaphragmatic weakness (HP:0009113) | 3.24892505 |
| 35 | Type 1 muscle fiber predominance (HP:0003803) | 3.24455167 |
| 36 | Syncope (HP:0001279) | 3.24376900 |
| 37 | Hypochromic anemia (HP:0001931) | 3.14143585 |
| 38 | * Abnormality of reticulocytes (HP:0004312) | 3.12671567 |
| 39 | Heart block (HP:0012722) | 3.11052990 |
| 40 | Nemaline bodies (HP:0003798) | 3.07621952 |
| 41 | Asymmetric septal hypertrophy (HP:0001670) | 3.01824428 |
| 42 | Acanthocytosis (HP:0001927) | 3.01474670 |
| 43 | Ventricular arrhythmia (HP:0004308) | 3.00943015 |
| 44 | Action tremor (HP:0002345) | 2.97840574 |
| 45 | Abnormal atrioventricular conduction (HP:0005150) | 2.96589298 |
| 46 | Calcaneovalgus deformity (HP:0001848) | 2.96060602 |
| 47 | Rhabdomyolysis (HP:0003201) | 2.93352739 |
| 48 | Ileus (HP:0002595) | 2.92356803 |
| 49 | Visual hallucinations (HP:0002367) | 2.91790251 |
| 50 | * Cholelithiasis (HP:0001081) | 2.91187668 |
| 51 | Difficulty climbing stairs (HP:0003551) | 2.91028852 |
| 52 | * Reticulocytosis (HP:0001923) | 2.88365865 |
| 53 | Increased variability in muscle fiber diameter (HP:0003557) | 2.87407823 |
| 54 | Distal arthrogryposis (HP:0005684) | 2.86635849 |
| 55 | Dilated cardiomyopathy (HP:0001644) | 2.80641311 |
| 56 | Toxemia of pregnancy (HP:0100603) | 2.80433676 |
| 57 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.72561147 |
| 58 | Right ventricular cardiomyopathy (HP:0011663) | 2.70355608 |
| 59 | Atrioventricular block (HP:0001678) | 2.65162917 |
| 60 | Abnormal EKG (HP:0003115) | 2.63619519 |
| 61 | Palpitations (HP:0001962) | 2.60068667 |
| 62 | Paralysis (HP:0003470) | 2.58701184 |
| 63 | Deformed tarsal bones (HP:0008119) | 2.57444966 |
| 64 | Insomnia (HP:0100785) | 2.56949643 |
| 65 | Myopathic facies (HP:0002058) | 2.50840982 |
| 66 | * Abnormal gallbladder morphology (HP:0012437) | 2.50658931 |
| 67 | Focal motor seizures (HP:0011153) | 2.50436302 |
| 68 | Focal seizures (HP:0007359) | 2.48813423 |
| 69 | * Hyperbilirubinemia (HP:0002904) | 2.47106949 |
| 70 | * Abnormality of the gallbladder (HP:0005264) | 2.46950690 |
| 71 | Lower limb amyotrophy (HP:0007210) | 2.44278480 |
| 72 | EMG: neuropathic changes (HP:0003445) | 2.43104634 |
| 73 | Prolonged bleeding time (HP:0003010) | 2.40612237 |
| 74 | Areflexia of lower limbs (HP:0002522) | 2.37482340 |
| 75 | Progressive cerebellar ataxia (HP:0002073) | 2.35757936 |
| 76 | Malignant hyperthermia (HP:0002047) | 2.34411274 |
| 77 | Round ear (HP:0100830) | 2.32711816 |
| 78 | Absent phalangeal crease (HP:0006109) | 2.31318742 |
| 79 | Depression (HP:0000716) | 2.29272759 |
| 80 | Neck muscle weakness (HP:0000467) | 2.28784776 |
| 81 | Limb-girdle muscle atrophy (HP:0003797) | 2.26827348 |
| 82 | Long clavicles (HP:0000890) | 2.24995023 |
| 83 | Dysdiadochokinesis (HP:0002075) | 2.23656346 |
| 84 | Pheochromocytoma (HP:0002666) | 2.23224739 |
| 85 | Hyperkalemia (HP:0002153) | 2.23110519 |
| 86 | Foot dorsiflexor weakness (HP:0009027) | 2.19414283 |
| 87 | Febrile seizures (HP:0002373) | 2.17037398 |
| 88 | Abnormality of the foot musculature (HP:0001436) | 2.16768362 |
| 89 | Myokymia (HP:0002411) | 2.16197911 |
| 90 | Distal lower limb muscle weakness (HP:0009053) | 2.15961037 |
| 91 | Impaired social interactions (HP:0000735) | 2.15545438 |
| 92 | Abnormal social behavior (HP:0012433) | 2.15545438 |
| 93 | Poor eye contact (HP:0000817) | 2.15545265 |
| 94 | Abnormality of iron homeostasis (HP:0011031) | 2.14140692 |
| 95 | Left ventricular hypertrophy (HP:0001712) | 2.13056572 |
| 96 | Distal lower limb amyotrophy (HP:0008944) | 2.12894357 |
| 97 | Abnormality of the fingertips (HP:0001211) | 2.12024341 |
| 98 | Abnormality of the calcaneus (HP:0008364) | 2.11211949 |
| 99 | Generalized tonic-clonic seizures (HP:0002069) | 2.09169856 |
| 100 | Gaze-evoked nystagmus (HP:0000640) | 2.04173714 |
| 101 | Generalized muscle weakness (HP:0003324) | 2.03729654 |
| 102 | Anxiety (HP:0000739) | 2.01075109 |
| 103 | Fetal akinesia sequence (HP:0001989) | 2.01004854 |
| 104 | Hypochromic microcytic anemia (HP:0004840) | 1.95406721 |
| 105 | Polycythemia (HP:0001901) | 1.93295148 |
| 106 | Postural instability (HP:0002172) | 1.92555872 |
| 107 | Neuroendocrine neoplasm (HP:0100634) | 1.92427448 |
| 108 | Cerebral palsy (HP:0100021) | 1.91449572 |
| 109 | Proximal amyotrophy (HP:0007126) | 1.89178536 |
| 110 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.88336924 |
| 111 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88152581 |
| 112 | Frequent falls (HP:0002359) | 1.87039838 |
| 113 | Atonic seizures (HP:0010819) | 1.85956256 |
| 114 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.84797546 |
| 115 | Weak cry (HP:0001612) | 1.84314618 |
| 116 | Ulnar deviation of the wrist (HP:0003049) | 1.83821011 |
| 117 | Abnormal gallbladder physiology (HP:0012438) | 1.82993386 |
| 118 | Cholecystitis (HP:0001082) | 1.82993386 |
| 119 | Abnormal finger flexion creases (HP:0006143) | 1.82135580 |
| 120 | Progressive muscle weakness (HP:0003323) | 1.81421968 |
| 121 | Broad-based gait (HP:0002136) | 1.80672825 |
| 122 | Rimmed vacuoles (HP:0003805) | 1.80251608 |
| 123 | Facial diplegia (HP:0001349) | 1.78245428 |
| 124 | Truncal ataxia (HP:0002078) | 1.78177143 |
| 125 | Muscular dystrophy (HP:0003560) | 1.76548557 |
| 126 | Gowers sign (HP:0003391) | 1.76205826 |
| 127 | Rapidly progressive (HP:0003678) | 1.75587642 |
| 128 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.75045197 |
| 129 | Slender build (HP:0001533) | 1.74702823 |
| 130 | Increased serum ferritin (HP:0003281) | 1.73168698 |
| 131 | Hypertensive crisis (HP:0100735) | 1.69630090 |
| 132 | Fatigue (HP:0012378) | 1.69097248 |
| 133 | Bowel incontinence (HP:0002607) | 1.64017533 |
| 134 | Hyponatremia (HP:0002902) | 1.63677483 |
| 135 | Bulbar palsy (HP:0001283) | 1.61906697 |
| 136 | Pallor (HP:0000980) | 1.58273057 |
| 137 | Osteomalacia (HP:0002749) | 1.57166792 |
| 138 | Abnormal large intestine physiology (HP:0012700) | 1.54585989 |
| 139 | Scapular winging (HP:0003691) | 1.54325879 |
| 140 | Abnormality of sodium homeostasis (HP:0010931) | 1.50462220 |
| 141 | Childhood onset (HP:0011463) | 1.48242734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.74886753 |
| 2 | PHKG2 | 4.30264968 |
| 3 | PHKG1 | 4.30264968 |
| 4 | PRPF4B | 3.94052753 |
| 5 | OBSCN | 3.46599126 |
| 6 | LMTK2 | 3.06785137 |
| 7 | TAOK2 | 2.53618394 |
| 8 | TRIB3 | 2.43467180 |
| 9 | PINK1 | 2.38779797 |
| 10 | NEK1 | 2.18232805 |
| 11 | DMPK | 2.08820754 |
| 12 | RIPK1 | 2.07869373 |
| 13 | WNK1 | 2.01087991 |
| 14 | PDK3 | 1.91069286 |
| 15 | PDK4 | 1.91069286 |
| 16 | PIK3CG | 1.89535483 |
| 17 | RIPK4 | 1.72709646 |
| 18 | NTRK3 | 1.68969926 |
| 19 | PKN2 | 1.67847344 |
| 20 | MUSK | 1.62832303 |
| 21 | CAMKK2 | 1.57746931 |
| 22 | MAP3K4 | 1.56239273 |
| 23 | MAP2K4 | 1.53793473 |
| 24 | STK38 | 1.47066944 |
| 25 | MYLK | 1.38498597 |
| 26 | PIK3CA | 1.35736146 |
| 27 | CDC42BPA | 1.34460246 |
| 28 | CAMKK1 | 1.34276300 |
| 29 | PAK6 | 1.31954141 |
| 30 | STK4 | 1.30073187 |
| 31 | PIM1 | 1.30013209 |
| 32 | PRKAA1 | 1.26822383 |
| 33 | MAP3K9 | 1.22116681 |
| 34 | MAP3K7 | 1.21570476 |
| 35 | MAPK12 | 1.20151313 |
| 36 | TAOK1 | 1.19864993 |
| 37 | CLK1 | 1.16739909 |
| 38 | MAP2K1 | 1.16423142 |
| 39 | SGK3 | 1.15899473 |
| 40 | MAP3K3 | 1.13022525 |
| 41 | MAP3K1 | 1.08932843 |
| 42 | MAP2K3 | 1.07988455 |
| 43 | MINK1 | 1.07962347 |
| 44 | DAPK2 | 1.07123812 |
| 45 | CCNB1 | 1.04015691 |
| 46 | CDK12 | 1.02795627 |
| 47 | MAP3K10 | 1.01983178 |
| 48 | EIF2AK1 | 0.99361486 |
| 49 | MAPKAPK3 | 0.97250500 |
| 50 | SCYL2 | 0.96992518 |
| 51 | RET | 0.87956684 |
| 52 | DYRK3 | 0.87305326 |
| 53 | PDK2 | 0.87227709 |
| 54 | ZAK | 0.87127157 |
| 55 | PRKCH | 0.86627994 |
| 56 | MARK3 | 0.85531518 |
| 57 | SYK | 0.85042650 |
| 58 | KSR2 | 0.84979551 |
| 59 | GRK6 | 0.84644634 |
| 60 | CAMK4 | 0.84208924 |
| 61 | SGK2 | 0.84157743 |
| 62 | PRKD1 | 0.83826911 |
| 63 | GRK5 | 0.83671112 |
| 64 | CAMK2D | 0.83230901 |
| 65 | HIPK2 | 0.82487475 |
| 66 | KSR1 | 0.82318053 |
| 67 | STK24 | 0.81168086 |
| 68 | BCKDK | 0.79964901 |
| 69 | SGK1 | 0.79533578 |
| 70 | GRK7 | 0.79466122 |
| 71 | CAMK1 | 0.79383271 |
| 72 | SGK223 | 0.77808374 |
| 73 | SGK494 | 0.77808374 |
| 74 | ROCK1 | 0.77319156 |
| 75 | PAK3 | 0.76720500 |
| 76 | DYRK1B | 0.76508530 |
| 77 | RAF1 | 0.74387110 |
| 78 | PRKAA2 | 0.74324363 |
| 79 | RPS6KA5 | 0.73692680 |
| 80 | PDPK1 | 0.70881050 |
| 81 | TRPM7 | 0.70707921 |
| 82 | STK11 | 0.70130454 |
| 83 | RPS6KC1 | 0.69797587 |
| 84 | RPS6KL1 | 0.69797587 |
| 85 | PDK1 | 0.69374526 |
| 86 | NME1 | 0.68615500 |
| 87 | ROCK2 | 0.68388615 |
| 88 | MARK2 | 0.67747217 |
| 89 | CAMK1G | 0.67346223 |
| 90 | EEF2K | 0.66359740 |
| 91 | CAMK1D | 0.65859009 |
| 92 | PKN1 | 0.65254671 |
| 93 | MAP3K8 | 0.63937846 |
| 94 | PRKD3 | 0.63679470 |
| 95 | RPS6KA3 | 0.63040544 |
| 96 | ALK | 0.62646231 |
| 97 | UHMK1 | 0.62538641 |
| 98 | CDK5 | 0.62419956 |
| 99 | CAMK2G | 0.61397380 |
| 100 | MAP2K7 | 0.59732628 |
| 101 | ICK | 0.58943801 |
| 102 | MARK1 | 0.58438681 |
| 103 | PRKACB | 0.57978349 |
| 104 | TIE1 | 0.56388500 |
| 105 | BRAF | 0.56224703 |
| 106 | RPS6KA6 | 0.55776898 |
| 107 | NTRK1 | 0.55386299 |
| 108 | CAMK2A | 0.54953840 |
| 109 | NTRK2 | 0.52738758 |
| 110 | PRKACG | 0.51878793 |
| 111 | MAPK11 | 0.51411338 |
| 112 | MAP3K5 | 0.50793382 |
| 113 | PTK2B | 0.50689457 |
| 114 | BRSK1 | 0.49479258 |
| 115 | MAP3K13 | 0.49085798 |
| 116 | MAP3K6 | 0.48489813 |
| 117 | MAPKAPK5 | 0.47804630 |
| 118 | DAPK3 | 0.47505424 |
| 119 | CDK19 | 0.47052713 |
| 120 | MTOR | 0.45229649 |
| 121 | AKT2 | 0.45166757 |
| 122 | JAK2 | 0.44878585 |
| 123 | RPS6KA2 | 0.43622868 |
| 124 | PRKACA | 0.42934907 |
| 125 | PDGFRA | 0.42233855 |
| 126 | PRKCG | 0.41736741 |
| 127 | WNK4 | 0.41410265 |
| 128 | MAP3K11 | 0.40998204 |
| 129 | EPHB1 | 0.40371075 |
| 130 | MAPK4 | 0.40360944 |
| 131 | SIK2 | 0.40016020 |
| 132 | BMX | 0.39373210 |
| 133 | PRKG1 | 0.39244415 |
| 134 | ZAP70 | 0.39094318 |
| 135 | MAPK10 | 0.37889955 |
| 136 | TNK2 | 0.35581628 |
| 137 | AKT1 | 0.32764732 |
| 138 | SIK1 | 0.32171787 |
| 139 | BTK | 0.30858046 |
| 140 | MAP2K6 | 0.30124945 |
| 141 | DYRK1A | 0.29850809 |
| 142 | RPS6KB1 | 0.28960610 |
| 143 | MAPK3 | 0.27004697 |
| 144 | RPS6KA1 | 0.26700772 |
| 145 | IKBKE | 0.26559023 |
| 146 | SMG1 | 0.22079806 |
| 147 | RPS6KB2 | 0.20844035 |
| 148 | CDC7 | 0.20733789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.04870838 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.53302666 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.39605136 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.96165189 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.78256879 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.47739916 |
| 7 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.33563066 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.16025744 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.04850388 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.97860028 |
| 11 | Nicotine addiction_Homo sapiens_hsa05033 | 1.87782344 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.82234707 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.73933995 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 1.73923660 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.65929720 |
| 16 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.64310009 |
| 17 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.59447340 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.58325403 |
| 19 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.55984506 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.55756335 |
| 21 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.54195964 |
| 22 | GABAergic synapse_Homo sapiens_hsa04727 | 1.52754423 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.52620146 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.52233076 |
| 25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.52204592 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.51748602 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.50240279 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.47715896 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.45837739 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.43295546 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.42935810 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.40810102 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.35379844 |
| 34 | Olfactory transduction_Homo sapiens_hsa04740 | 1.33633744 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32340473 |
| 36 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.32319706 |
| 37 | Alzheimers disease_Homo sapiens_hsa05010 | 1.31624533 |
| 38 | Morphine addiction_Homo sapiens_hsa05032 | 1.31618284 |
| 39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.31207830 |
| 40 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.23951007 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.23528847 |
| 42 | Taste transduction_Homo sapiens_hsa04742 | 1.23384010 |
| 43 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.22331340 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22226578 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.19606062 |
| 46 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.18378948 |
| 47 | Long-term depression_Homo sapiens_hsa04730 | 1.16195309 |
| 48 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.13031077 |
| 49 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.12955191 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.12811887 |
| 51 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.12126255 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 1.08689205 |
| 53 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.08651048 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04204867 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.03203107 |
| 56 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.02635905 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02311799 |
| 58 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.01512969 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00171517 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98236093 |
| 61 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.96564052 |
| 62 | Alcoholism_Homo sapiens_hsa05034 | 0.96497105 |
| 63 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.96456347 |
| 64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.96456116 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.96402704 |
| 66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.96041417 |
| 67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95538395 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95134754 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94633122 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94049474 |
| 71 | Gap junction_Homo sapiens_hsa04540 | 0.93985611 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90259634 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.89875719 |
| 74 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.88896100 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.88627876 |
| 76 | Huntingtons disease_Homo sapiens_hsa05016 | 0.83047585 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.81750795 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81168768 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80196971 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.79815139 |
| 81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78913989 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75892460 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75648227 |
| 84 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75286311 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74889321 |
| 86 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74311520 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73707931 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70506079 |
| 89 | Cell cycle_Homo sapiens_hsa04110 | 0.69929309 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68383102 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.68234641 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67666180 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67596700 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.67463028 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67246417 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.67014250 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.66157478 |
| 98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63589813 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61648187 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61631340 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58520719 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58163525 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58114612 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57655593 |
| 105 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56929192 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56851918 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56757015 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56172206 |
| 109 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54007453 |
| 110 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53937980 |
| 111 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51962395 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50826357 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49643631 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49507201 |
| 115 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49469102 |
| 116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49095084 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.48905673 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48612375 |
| 119 | Platelet activation_Homo sapiens_hsa04611 | 0.47561970 |
| 120 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47530600 |
| 121 | ABC transporters_Homo sapiens_hsa02010 | 0.47061021 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46068265 |
| 123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45856680 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.45123229 |
| 125 | Hepatitis B_Homo sapiens_hsa05161 | 0.44284075 |
| 126 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.44023778 |
| 127 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43645289 |
| 128 | Prostate cancer_Homo sapiens_hsa05215 | 0.43507210 |
| 129 | Focal adhesion_Homo sapiens_hsa04510 | 0.43374007 |
| 130 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42976174 |
| 131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41599774 |
| 132 | Tight junction_Homo sapiens_hsa04530 | 0.41389572 |
| 133 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39780143 |
| 134 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.38997151 |

